''The expansion of Relenza capacity and any increase in resultant royalty payments, will not effect Biota�fs cash position until June 2010, at the earliest."
How can this be true if GSK is gearing up production to 190 million packs by End of December 2009. We will see massive royalties in the next two qaurters as a direct reult of this expansion.
''While the positive effect of this expansion on Biota may be significant and GSK have confirmed it has contracts to supply Relenza to over 60 countries, the announcement is focussed on increased manufacturing capacity for Relenza, not orders or sales.''
What the !!
This implies the GSK statement is all about production but the paragraph says 60 countries have placed contracts or in other words ORDERS/ SALES.
I could go on and on but the bingo is on soon at the RSL so must be off.
BTA Price at posting:
$1.76 Sentiment: ST Buy Disclosure: Held
